Patent · US Active

Heterocyclic compounds and uses thereof

US9255108B2 · kind B2 · utility

21Cited by

244References

45Claims

0Family size

Assignee

Infinity Pharmaceuticals, Inc. · US

Inventors

Alfredo C. Castro · Woburn, US
Katrina Chan · Fremont, US
Catherine A. Evans · Somerville, US
Somarajannair Janardanannair · Woburn, US
Andre Lescarbeau · Somerville, US
Liansheng Li · San Diego, US
Tao Liu · Shanghai, CN
Yi Liu · San Diego, US
Pingda Ren · San Diego, US
Daniel A. Snyder · Somerville, US
Martin Tremblay · Waltham, US

Key dates

Filing date	Dec 17, 2014
Grant date	Feb 9, 2016
Priority date	—
Expiry date	Dec 17, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.